Skip to main content
Top

Journal of Cancer Research and Clinical Oncology

Issue 3/1997

Content (9 Articles)

Guest Editorial

High-mobility-group proteins and cancer—an emerging link

Volker Wunderlich, Michael Böttger

Original Paper

DNA adducts in human placenta in relation to tobacco smoke exposure and plasma antioxidant status

Helmut Daube, Gerhard Scherer, Kirsten Riedel, Thomas Ruppert, Anthony R. Tricker, Peter Rosenbaum, Franz Adlkofer

Original Paper

Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells

Yael Zimra, Lina Wasserman, Lea Maron, Mati Shaklai, Abraham Nudelman, Ada Rephaeli

Original Paper

Expression of epidermal growth factor receptor in gestational trophoblastic diseases

Prabha Balaram, Molykutty John, T. N. Rajalekshmy, Balaraman Nair, Gregory Schultz, Krishnan Nair

Original Paper

Serum levels of interleukins, growth factors and anglogenin in patients with endometrial cancer

Vimlarani Chopra, Tung V. Ding, Edward V. Hanningan

Original Paper

Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial

Barbara D. Wamil, Gary B. Thurman, Hakan W. Sundell, Russel F. DeVore, Gail Wakefield, David H. Johnson, Yue-Fen Wang, Carl G. Hellerqvist

Original Paper

Surgical therapy for localized prostatic carcinoma

Joachim Noldus, Peter Hammerer, Markus Graefen, Hartwig Huland

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.